Chronic inflammation and ensuing fibrosis result in progressive destruction of the lung following Pseudomonas aeruginosa infection in cystic fibrosis (CF), the most common lethal genetic disease of Caucasians. Specific virulence factors of P.aeruginosa facilitate its recognition of receptors available on the CF respiratory epithelial cell. Pseudomonas adhesins such as pili and flagella and certain exoproducts elicit an IL-8 response by respiratory epithelial cells which initiates the polymorphonuclear leucocyte dominated inflammation of the CF airways. A detailed analysis of the molecular interactions between the bacterial ligands and their receptors is proposed. Pili are the best characterized P.aeruginosa ligands although the precise biochemical components of the ligand-receptor binding remain undefined. Flagella are highly conserved bacterial organelles which allow for chemotaxis toward preferred carbon substrates, in vivo as well as in vitro. The significance of glycosylation of P.aeruginosa pilin will be examined to determine if this post translational modification is a common property of clinical isolates of P.aeruginosa, if glycosylation affects the adhesive properties of pill, and if glycosylated pill represent an adaptation to the host immune response. The role of flagellin as an adhesin and essential virulence factor will be explored using genetic methods to separate a motility function from a putative adhesin domain. P.aeruginosa exoproducts and central regulatory loci which enable the organism to efficiently colonize the lung will be identified. Exoproducts which are expressed specifically in response to the environment posed by the human airway epithelium will be studied and regulatory elements which coordinate their expression will be defined. Identification of the gene products expressed in the initial stages of infection may provide potential targets for therapeutic intervention. We postulate that the unique association of P.aeruginosa and the CF lung can be attributed to this genetic repertoire; the ability to attach, colonize, infect and adapt to the conditions imposed by the milieu of the airways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK039693-11
Application #
2905369
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Mckeon, Catherine T
Project Start
1991-07-01
Project End
2000-11-30
Budget Start
1999-07-01
Budget End
2000-11-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Chun, Jarin; Prince, Alice (2009) TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 5:47-58
Soong, Grace; Parker, Dane; Magargee, Mariah et al. (2008) The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol 190:2814-21
Gomez, Marisa I; Prince, Alice (2007) Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 7:244-51
Soong, Grace; Muir, Amanda; Gomez, Marisa I et al. (2006) Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 116:2297-2305
Gomez, Marisa I; Sokol, Sach H; Muir, Amanda B et al. (2005) Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol 175:1930-6
Muir, Amanda; Soong, Grace; Sokol, Sach et al. (2004) Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30:777-83
Soong, Grace; Reddy, Bharat; Sokol, Sach et al. (2004) TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 113:1482-9
Saiman, L; Sadoff, J; Prince, A (1989) Cross-reactivity of Pseudomonas aeruginosa antipilin monoclonal antibodies with heterogeneous strains of P. aeruginosa and Pseudomonas cepacia. Infect Immun 57:2764-70